Clinical Trials in Arizona

Showing 3301-3320 of 8,032 trials

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

NCT05006885

The purpose of the study is to assess the safety and tolerability of ALT-801 in diabetic and non-diabetic subjects with overweight and obese and non-alcoholic fatty liver disease (NAFLD).

Non-Alcoholic Fatty Liver Disease

Altimmune, Inc.95 participantsStarted Sep 2021

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Montclair, California, United States +12 more locations

COMPLETEDPhase 131 miles

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

NCT04456140

This phase I trial collects blood samples to investigate the prevalence of changes in genes (genetic mutations) in solid tumor patient populations seeking care at Mayo Clinic Embedded Cancer Center at St. Vincent's Riverside. This may help doctors better understand and/or treat others who have genetic mutations.

Breast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more

Mayo Clinic230 participantsStarted Jun 2020

Scottsdale, Arizona, United States • Jacksonville, Florida, United States

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Find Trials by Condition in Arizona

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Evaluation of C-Scan Capsule in Identifying Subjects With Elevated Risk of Colon Polyps

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

FreeStyle Libre 3 Continuous Glucose Monitoring System

Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery

Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks